Exenatide Extended-Release: A Review of Its Use in Type 2 Diabetes Mellitus

ISSN： 0012-6667

Source： Drugs, Vol.72, Iss.12, 2012-08, pp. : 1679-1707

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Exenatide: A Review of Its Use in Patients with Type 2 Diabetes Mellitus (as an Adjunct to Metformin and/or a Sulfonylurea)

By Cvetković Risto S. Plosker Greg L.

Drugs, Vol. 67, Iss. 6, 2007-01 ,pp. : 935-954

Adis International

Access to resources Recommend Favorite

Glipizide: A Review of the Pharmacoeconomic Implications of the Extended-Release Formulation in Type 2 Diabetes Mellitus

By Foster R.H. Plosker G.L.

PharmacoEconomics, Vol. 18, Iss. 3, 2000-09 ,pp. : 289-306

Adis International

Access to resources Recommend Favorite

Exenatide: a guide to its use as an adjunct to metformin and/or a sulfonylurea in patients with type 2 diabetes mellitus

By Adis International Limited

Drugs & Therapy Perspectives, Vol. 23, Iss. 10, 2007-10 ,pp. : 5-8

Adis International

Access to resources Recommend Favorite

Exenatide once weekly in type 2 diabetes mellitus

By Bischoff Lindsay A Jabbour Serge A Miller Jeffrey L

Expert Opinion on Pharmacotherapy, Vol. 12, Iss. 8, 2011-06 ,pp. : 1297-1303

Informa Healthcare

Access to resources Recommend Favorite

Troglitazone: A Review of its Use in the Management of Type 2 Diabetes Mellitus

By Plosker G.L. Faulds D.

Drugs, Vol. 57, Iss. 3, 1999-03 ,pp. : 409-438

Adis International

Access to resources Recommend Favorite